908 Devices Corporation (MASS) - Rasio tanggungan utang jangka dawa marang modal

908 Devices Inc. - logo grafis emiten MASS

908 Devices Inc. (MASS) utilizes external chip supplies with internal calibration, as evidenced by the price chart where the individual long-term debt metric equals 0.03. The company's financial stability relies on growing interest from biotech laboratories in mobile devices. However, the business remains sensitive to government budget fluctuations and lengthy deals with a limited circle of major counterparties.

908 Devices (MASS): Utang jangka dawa marang modal saka 04.07.2022 nganti 29.10.2026
Sampel barang 908 Devices Corp

Developing compact mass spectrometers requires significant investment in highly skilled engineering personnel, making the control of long-term leverage critical for the financial stability of 908 Devices Inc. (MASS). The current ratio of long-term debt to equity at 0.03 demonstrates the business's degree of dependence on borrowed capital with maturities exceeding one year, allowing investors to assess the debt load risk when scaling technological production.

Perusahaan pesaing

Rasio utang jangka dawa marang modal ABT (Abbott Labs)|Utang jangka dawa marang modal TMO|Rasio tanggungan utang jangka dawa marang modal GE HealthCare Inc.|Utang jangka dawa marang modal MTD (Mettler-Toledo International)|Utang jangka dawa marang modal waters.com WAT|Bio-Techne - Utang jangka dawa marang modal|Tanggungan utang jangka dawa marang ekuitas Bruker Corp (BRKR)|Azenta Life Sciences (AZTA) - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang modal VREX|Utang jangka dawa marang ekuitas Semler Scientific, Inc.|Kewajiban jangka dawa marang modal butterflynetwork.com BFLY|Utang jangka dawa marang ekuitas Mesa Labs (MLAB)|Rasio tanggungan utang jangka dawa marang modal Quantum-Si Inc.|Nanox - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka dawa marang modal QTRX (Quanterix Inc)|CapsoVision Medical - Utang jangka dawa marang modal|Rasio tanggungan utang jangka dawa marang modal maxcyte.com MXCT|RPID: Utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas Seer Inc|Rasio utang jangka dawa marang ekuitas HYPR|FONR: Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Daxor Corporation (DXR)|Rasio utang jangka dawa marang ekuitas Spectral AI Inc. MDAI|Utang jangka dawa marang modal VIVS (Organovo Holdings, Inc.)|Aclarion Inc (ACON) - Kewajiban jangka dawa marang modal|Akoya - Utang jangka dawa marang modal|THMO (Cesca Therapeutics) - Rasio utang jangka dawa marang modal|TLIS: Utang jangka dawa marang modal|TTOO - Rasio tanggungan utang jangka dawa marang modal